Pharmacologic properties of etizolam (6- (o-chlorophenyl) -8-ethyl-1-methyl-4H-s-triazolo 3,4-c thieno 2,3-e 1,4 diazepine)
Monti, E.; Fornara, C.; Brembilla, E.; Dall'Oglio, A.
Minerva Psichiatrica 25(4): 269-274
1984
ISSN/ISBN: 0374-9320 PMID: 6527637 Document Number: 227405
Document emailed within 1 workday
Related Documents
Guryn, R.; Szadowska, A.; Kiełek, M.B. 1988: Synthesis and pharmacologic properties of s-triazolo-1,4-diazepine derivatives Acta Poloniae Pharmaceutica 45(6): 512-516Lardy, C.; Rousselot, C.; Chavernac, G.; Depin, J.C.; Guerrier, D. 1994: Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate Arzneimittel-Forschung 44(11): 1196-1202
Ivashchenko, A.V.; Kadieva, M.G.; Mit'kin, O.D.; Kravchenko, D.V.; Salimov, R.M.; Skrabelinskaia, E.I.; Fedotov, I.A.; Lavrovskiĭ, I.V. 2010: Toxicity of ethyl-3-(8-fluoro-2-methyl-2,3,4,5-tetrahydropyrido[4,3-b]indol-5-yl)-propionate dihydrochloride possessing antiallergic properties Eksperimental'naia i Klinicheskaia Farmakologiia 73(6): 33-35
Gemba, T.; Ninomiya, M.; Matsunaga, K.; Ueda, M. 1993: Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 265(1): 463-467
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Ombetta, J.E.; Lyet, S.; Xicluna, A.; Robert, J.F.; Panouse, J.J. 1988: Preparation and pharmacologic approach of a series of dihydro-4,5 thieno(2,3-c)quinoline-4-ones Annales Pharmaceutiques Francaises 46(6): 377-389
Pavelescu, M.; Gafiţanu, E.; Dăneţ, R.; Sunel, V. 1984: Antipyretic activity of a new anti-inflammatory thiazole compound 2-(4-chlorophenyl)-thiazo-4-yl ethyl acetate in rats Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 88(3): 551-553
Eguchi, J.; Inomata, Y.; Yuasa, T.; Egawa, M.; Saito, K. 1997: Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride Arzneimittel-Forschung 47(12): 1337-1347
Wagner, G.; Vieweg, H.; Leistner, S. 1993: Synthesis of 4-methyl-6-phenyl-thieno(2,3-d)pyrimidines with a formamidino- or oxalamidocarbonic acid residue with antianaphylactic activity Die Pharmazie 48(9): 667-669
Toyo-oka, T.; Kamishiro, T.; Gotoh, Y.; Fumino, H.; Masaki, T.; Hosoda, S. 1986: Temporary salvage of ischemic myocardium by the protease inhibitor bis[ethyl(2R,3R)-3-[(S)-methyl-1-[4-(2,3,4-trimethoxyphenyl-methyl) piperazin-1-ylcarbonyl]butyl-carbonyl]oxiran-2-carbo xylate]sulfate Arzneimittel-Forschung 36(4): 671-675
Pfeifer, S.; Pöhlmann; Bornschein, P.; Kraft, R. 1975: Analysis and biochemistry of aza analogs of methaqualone. 4. Biotransformation of 2-methyl-3-(4'-chlorophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidine Die Pharmazie 30(5): 290-296
Zimmer, H.; Kokosa, J.; Garteiz, D.A. 1973: Identification of 3-methyl-s-triazolo(3,4-alphathalazine, a human hydralazine metabolite, by gas chromatography-mass spectrometry Arzneimittel-Forschung 23(8): 1028-1029
Högberg, T.; Bondesson, G.; Stjernström, N.E. 1977: Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate Acta Pharmaceutica Suecica 14(2): 149-160
Baraldi, P.G.; Cacciari, B.; Spalluto, G.; Pineda de las Infants, M.J.; Zocchi, C.; Ferrara, S.; Dionisotti, S.; FerraDDionisotti, S. 1996: 1,2,3-Triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: a new class of A2A adenosine receptor antagonists Farmaco 51(4): 297-300
Rinaldi, M.; Pecorari, P.; Costantino, L.; Provvisionato, A.; Malagoli, M.; Cermelli, C. 1992: Synthesis and biological activity of new heterocyclic structures: [1,3]thiazino[2,3-i]purine, thiazolo[3,2-c] [1,2,3]triazolo[4,5-e]pyrimidine and [1,2,3]triazolo [4', 5': 4,5] pyrimido[6,1-b][1,3]thiazine Farmaco 47(10): 1315-1322
Sladowska, H.; Zawisza, T. 1986: Synthesis and properties of amides of 1-benzyl-3-methyl- and 1-butyl-3-phenyl-7-methyl-4-oxo-2-thioxo (2,4-dioxo)-1,2,3,4-tetrahydropyrido-[2,3-d]pyrimidine-6-carboxy lic acids Il Farmaco; Edizione Scientifica 41(12): 954-963
Wagner, G.; Leistner, S.; Vieweg, H.; Krasselt, U.; Prantz, J. 1993: Synthesis of thieno(2,3-b)pyridines with oxalamidic acid or an oxalamidic alkylester residues and of 4-alkoxy-pyrido(3',2':4,5)thieno(3,2-d)pyridine-2-carboxylic acid derivates Die Pharmazie 48(5): 342-346
Saxena, R.; Iyer, R.N.; Anand, N.; Chatterjee, R.K.; Sen, A.B. 1970: 3-Ethyl-8-methyl-1,3,8-triazabicyclo(4,4,0)decan-2-one: a new antifilarial agent Journal of Pharmacy and Pharmacology 22(4): 306-307
Nalini, G.; Namasivayam, A. 1992: Influence of ethyl and methyl alcohol on rat brain histamine content Indian Journal of Physiology and Pharmacology 36(4): 285-286